期刊
INFECTION
卷 46, 期 3, 页码 431-434出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s15010-018-1125-5
关键词
Ceftolozane-tazobactam; Pseudomonas aeruginosa; Hematologic malignancy; Hematopoietic-cell transplant
Multidrug-resistant (MDR) Pseudomonas aeruginosa infection causes significant mortality among patients with hematologic malignancies and hematopoietic-cell transplant recipients. Ceftolozane-tazobactam (C-T) is a novel therapeutic option for MDR-P. aeruginosa infections but clinical experience in these patients is limited. We report favorable clinical outcomes and lack of limiting toxicities using C-T monotherapy to treat invasive MDR-P. aeruginosa infections in these patient populations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据